| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
IR-Med Inc (PINK: IRME)
IRME Technical Analysis
5
| As on 26th Aug 2025 IRME STOCK Price closed @ 0.02 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.12 & Strong Sell for SHORT-TERM with Stoploss of 1.11 we also expect STOCK to react on Following IMPORTANT LEVELS. |
IRMESTOCK Price
| Open | 0.02 | Change | Price | % |
| High | 0.02 | 1 Day | 0.01 | 100.00 |
| Low | 0.02 | 1 Week | 0.01 | 100.00 |
| Close | 0.02 | 1 Month | -0.11 | -84.62 |
| Volume | 14001 | 1 Year | -1.16 | -98.31 |
| 52 Week High 1.65 | 52 Week Low 0.01 | ||||
PINK USA Most Active Stocks
| GRLF | 0.00 | % |
| ENDV | 0.00 | % |
| RDAR | 0.00 | % |
| TXGE | 3316.21 | 2.69% |
| NUKK | 4.87 | 31.98% |
| OZSC | 0.00 | % |
| AITX | 0.00 | % |
| RITE | 0.01 | % |
| GRLT | 0.00 | % |
| HADV | 0.00 | % |
PINK USA Top Gainers Stocks
PINK USA Top Losers Stocks
| IRME Daily Charts |
IRME Intraday Charts |
Whats New @ Bazaartrend |
IRME Free Analysis |
|
|
IRME Important Levels Intraday
| RESISTANCE | 0.02 |
| RESISTANCE | 0.02 |
| RESISTANCE | 0.02 |
| RESISTANCE | 0.02 |
| RESISTANCE | 0.02 |
| RESISTANCE | 0.02 |
| RESISTANCE | 0.02 |
| RESISTANCE | 0.02 |
IRME Forecast September 2025
| 4th UP Forecast | 0.66 |
| 3rd UP Forecast | 0.45 |
| 2nd UP Forecast | 0.33 |
| 1st UP Forecast | 0.2 |
| 1st DOWN Forecast | -0.16 |
| 2nd DOWN Forecast | -0.29 |
| 3rd DOWN Forecast | -0.41 |
| 4th DOWN Forecast | -0.62 |
IRME Weekly Forecast
| 4th UP Forecast | 0.29 |
| 3rd UP Forecast | 0.20 |
| 2nd UP Forecast | 0.15 |
| 1st UP Forecast | 0.10 |
| 1st DOWN Forecast | -0.06 |
| 2nd DOWN Forecast | -0.11 |
| 3rd DOWN Forecast | -0.16 |
| 4th DOWN Forecast | -0.25 |
IRME Forecast2025
| 4th UP Forecast | 3.18 |
| 3rd UP Forecast | 2.17 |
| 2nd UP Forecast | 1.54 |
| 1st UP Forecast | 0.91 |
| 1st DOWN Forecast | -0.87 |
| 2nd DOWN Forecast | -1.5 |
| 3rd DOWN Forecast | -2.13 |
| 4th DOWN Forecast | -3.14 |
IR-Med Inc ( PINK USA Symbol : IRME )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
IRME Business Profile
IR-Med Inc., a medical device company, focuses on the development of infra-red light spectroscopy (IR) and artificial intelligence (AI) combined technology solutions to address the diagnosis of medical ailments. It develops PressureSafe, a non-invasive and real-time optical monitoring device for the preemptive detection of pressure injury; and Nobiotics, an advanced otoscope that works on IR-spectrographic analysis technology providing doctors an immediate indication of the infection being viral or bacterial. The company also engages in developing a real-time noninvasive optical monitor to determine Propofol blood concentration. Its products are used for applications in pressure injury, ear inflammation, and other pharmaceutical areas. IR-Med Inc. is headquartered in Rosh Pina, Israel. Address: Ts.Kh.R Industrial Zone, Rosh Pinna, Israel, 1210002
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service